Vimarsana
Biggest News Aggregation in the World

Cardiac Toxicity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cardiac Toxicity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cardiac Toxicity Today - Breaking & Trending Today

HER2+ mBC: Emerging Agents in the Third-Line and Higher Setting - Vimarsana News

HER2+ mBC: Emerging Agents in the Third-Line and Higher Setting

Published: August 3, 2023

Debu Tripathy, MD, discusses novel therapies being developed for later-line treatment of HER2+ mBC.

Source: onclive.com
Related Topics:
San AntonioUnited StatesSara HurvitzBreast CancerHer2 Breast CancerHer2 Positive Breast CancerMetastatic Breast CancerThird Line TherapyAntibody Drug ConjugatesBispecific AntibodyI Spy TrialTulip TrialPatina TrialJcdk4 6 InhibitorMaintenance TherapyHer2 Cart Cell TherapyCardiac ToxicityTyrosine Kinase InhibitorsIc Trastuzumab Duocarmazine
Remaining Unmet Needs in the Third-Line and Lessons from HER2CLIMB - Vimarsana News

Remaining Unmet Needs in the Third-Line and Lessons from HER2CLIMB

Published: July 27, 2023

Drs Tripathy and Kaklamani emphasize the most critical unmet needs for patients with HER2+ metastatic breast cancer in the third-line or higher settings and recap what the field previously learned from the HER2CLIMB trial of tucatinib/trastuzumab/capecitabine.

Source: onclive.com
Related Topics:
Sara HurvitzBreast CancerHer2 Breast CancerHer2 Positive Breast CancerMetastatic Breast CancerThird Line TherapyBrain MetastasesCns MetastasesCumulative ToxicityCardiac ToxicityTyrosine Kinase InhibitorsTopoisomerase InhibitorsAntibody Drug ConjugatesTrastuzumab DeruxtecanTrastuzumab EmtansineT Dm1T DxdCns Progression